Search | Médecins Sans Frontières Access Campaign

18 results found
There is 1 active filter
Clear all filters
United States of America

18 results found

Letter |

30 March 2022

US civil society letter to the President on COVID-19 Waiver leaked text

US CSO letter to President Biden on COVID-19 TRIPS Waiver leaked text

Tags COVID-19 coronavirus United States of America

A member of MSF’s mobile vaccination team prepares a dose of COVID-19 vaccine.

Press release |

23 August 2021

Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply

Sharing mRNA vaccine technology with manufacturers in low- and middle-income countries could offer sustainable, equitable access to COVID-19 vaccines

Tags COVID-19 coronavirus vaccines access to medicines United States of America

Letter |

30 June 2021

Letters to US President and Trade Representative to swiftly implement IP waiver of all COVID-19 medical tools

Open letters to US President Biden and to US Trade Representative to swiftly implement the WTO TRIPS Waiver on IP of all COVID-19 medical tools

Tags COVID-19 coronavirus TRIPS WTO United States of America

MSF nurse gives COVID-19 vaccination at an Elderly Nursing Home In Chlifa Baalbak, Lebanon

Press release |

26 April 2021

MSF welcomes US decision to share AstraZeneca COVID-19 vaccines

MSF welcomes the Biden Administration’s decision to donate AstraZeneca COVID-19 vaccine doses to other countries. As the US has secured far more vaccines than it needs, sharing surplus doses with the rest of the world would ensure more ...

Tags COVID-19 coronavirus AstraZeneca covid medical tools access United States of America

MSF medical mobile teams vaccinating Elderly people and frontline Healthcare workers in a nursing home in Tripoli.

Press release |

19 April 2021

Biden Administration must take bold action to ensure global COVID-19 vaccine access

The Biden Administration should take urgent action and begin sharing surplus COVID-19 vaccine doses to protect millions of people who have been left out of the global vaccine rollout, said the medical humanitarian organization MSF ...

Tags COVID-19 coronavirus covid medical tools access United States of America

Technical brief |

26 January 2021

Transparency Matters: Disclosing the Costs of Publicly Funded Research & Development for COVID-19 Medical Tools and Beyond

High prices limit people’s access to lifesaving vaccines, therapeutics, and diagnostics the world over. The pharmaceutical industry often claims that the high costs of research and development (R&D) – clinical trials, in particular – ...

Tags COVID-19 coronavirus covid medical tools access United States of America

Hanif is 25 years old, lives in Mumbai, and is one of only a handful of extensively drug-resistant TB (XDR-TB) patients in India lucky enough to be able to have acesss to the new drugs. After having failed treatment for the fourth time, Hanif was referred to the clinic of Medecins Sans Frontieres (MSF) / Doctors Without Borders, an international medical humanitarian organisation who since 2006 provides free diagnosis, treatment and support to patients with drug-resistant TB in Mumbai.

Press release |

01 May 2020

MSF responds to USTR 2020 Special 301 Report

Amidst the ongoing global crisis caused by the COVID-19 pandemic, the United States Trade Representative (USTR) released its annual “Special 301 Report” targeting countries for implementing and supporting public health safeguard in ...

Tags Intellectual property and trade United States of AmericaIndia

Because of COVID-19 MSF has increased its activities in the camp with more comprehensive care staff. Also, the organization has been in touch with immigration and health authorities to have a better understanding and plan of action to be prepared in case a COVID-19 patient is detected.

Photograph by MSF

Press release |

27 March 2020

US must include asylum seekers in COVID-19 response, rather than shut border

The United States government’s decision to block asylum proceedings and close the US-Mexico border, with the justification to stem the spread of the coronavirus pandemic, threatens the health and safety of thousands of people seeking international protection in the United States who are then forced to return to Mexico, says MSF.

Statement |

07 February 2020

MSF submission to USTR 2020 Special 301 Report review process

The USTR called for comments from stakeholders for their 2020 Special 301 Report. The Special 301 Report is an annual report by the USTR that names countries on "watch lists" in line with its powerful pharmaceutical industry's demands ...

Tags Intellectual property and trade United States of AmericaIndia

Press release |

23 September 2019

MSF urges PM Modi not to make any trade commitments to US threatening access to medicines

“India should be cautious while signing any trade package or launching trade negotiations with the US that may include harmful provisions threatening India’s ability to produce and supply affordable medical products. Going by past ...

Tags Intellectual property and trade United States of AmericaIndia

Press release |

20 February 2019

Novartis secures FDA innovation prize for 30-year-old drug

Most recent Priority Review Voucher is a reminder of why Congress should reform the US government program to only reward companies for developing new and affordable drugs and vaccines for neglected diseases

Tags Intellectual property and trade FDA priority review voucher Novartis United States of America